Epcoritamab-bysp bulk supplier for pharma manufacturers

Epcoritamab-Bysp Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 4 mg/0.8 mL, 48 mg/0.8 mL

Reference Brands: EPKINLY (USA)

Category: Oncology Cancer Care

Epcoritamab-bysp is available in Injection and strengths such as 4 mg/0.8 mL, 48 mg/0.8 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Epcoritamab-bysp is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Epcoritamab-bysp can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

What is Epcoritamab-bysp made from? Epcoritamab-bysp is made from Epcoritamab-bysp, a bispecific humanized monoclonal antibody that binds both CD3 on T-cells and CD20 on B-cells to promote immune-mediated destruction of cancerous B-cells.

What is trade name of Epcoritamab-bysp? The trade name of Epcoritamab-bysp is Epkinly.

What company makes Epcoritamab-bysp? Epcoritamab-bysp (Epkinly) is developed and manufactured by Genmab and AbbVie and marketed under approved regulatory pathways for B-cell lymphoma.

What is generic name of Epcoritamab-bysp? The generic name of Epcoritamab-bysp is Epcoritamab-bysp.

What is brand name of Epcoritamab-bysp? The brand name of Epcoritamab-bysp is Epkinly.

Where is Epcoritamab-bysp manufactured? Epcoritamab-bysp is manufactured in the United States and Europe by Genmab and AbbVie under strict GMP conditions for oncology therapeutics.

Yes, Epcoritamab-bysp is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Epcoritamab-bysp is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Imlunestrant Tosylate

Strength:
200 mg

Form: Tablets

Reference Brands: Inluriyo (USA)

View Details
Tarlatamab-Dlle.

Strength:
1 mg, 10 mg

Form: Injection

Reference Brands: Imdelltra (USA), Imdylltra (EU/UK)

View Details
Ponatinib Hydrochloride

Strength:
10 mg, 15 mg, 30 mg, 45 mg

Form: Tablets

Reference Brands: Iclusig (USA)

View Details
Taletrectinib

Strength:
200 mg

Form: Capsules

Reference Brands: Ibtrozi (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.